GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (FRA:2H51) » Definitions » Other Gross PPE

Ocugen (FRA:2H51) Other Gross PPE : €15.37 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ocugen Other Gross PPE?

Ocugen's Other Gross PPE for the quarter that ended in Dec. 2024 was €15.37 Mil.

Ocugen's quarterly Other Gross PPE declined from Jun. 2024 (€14.87 Mil) to Sep. 2024 (€14.50 Mil) but then increased from Sep. 2024 (€14.50 Mil) to Dec. 2024 (€15.37 Mil).

Ocugen's annual Other Gross PPE increased from Dec. 2022 (€1.51 Mil) to Dec. 2023 (€1.91 Mil) and increased from Dec. 2023 (€1.91 Mil) to Dec. 2024 (€15.37 Mil).


Ocugen Other Gross PPE Historical Data

The historical data trend for Ocugen's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen Other Gross PPE Chart

Ocugen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.15 1.51 1.91 15.37

Ocugen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 1.92 14.87 14.50 15.37

Ocugen Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Ocugen Business Description

Traded in Other Exchanges
Address
11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen Headlines

No Headlines